Amniotic fluid interleukin-6 and the risk of early-onset sepsis among preterm infants.

R. Figueroa-Damián,J. Arredondo-García,J. Mancilla-Ramírez

DOI: https://doi.org/10.1016/S0188-0128(99)00015-9

IF: 8.323

1999-05-01

Archives of Medical Research

Abstract:

What problem does this paper attempt to address?

Functional Human IgA Targets a Conserved Site on Malaria Sporozoites

Joshua Tan,Hyeseon Cho,Tossapol Pholcharee,Lais S. Pereira,Safiatou Doumbo,Didier Doumtabe,Barbara J. Flynn,Arne Schon,Sachie Kanatani,Samantha O. Aylor,David Oyen,Rachel Vistein,Lawrence Wang,Marlon Dillon,Jeff Skinner,Mary Peterson,Shanping Li,Azza H. Idris,Alvaro Molina-Cruz,Ming Zhao,Lisa Renee Olano,Patricia J. Lee,Alison Roth,Photini Sinnis,Carolina Barillas-Mury,Kassoum Kayentao,Aissata Ongoiba,Joseph R. Francica,Boubacar Traore,Ian A. Wilson,Robert A. Seder,Peter D. Crompton

DOI: https://doi.org/10.1126/scitranslmed.abg2344

IF: 17.1

2021-01-01

Science Translational Medicine

Abstract:Immunoglobulin (Ig)A antibodies play a critical role in protection against mucosal pathogens. However, the role of serum IgA in immunity to nonmucosal pathogens, such as Plasmodium falciparum, is poorly characterized, despite being the second most abundant isotype in blood after IgG. Here, we investigated the circulating IgA response in humans to P. falciparum sporozoites that are injected into the skin by mosquitoes and migrate to the liver via the bloodstream to initiate malaria infection. We found that circulating IgA was induced in three independent sporozoite-exposed cohorts: individuals living in an endemic region in Mali, malaria-naïve individuals immunized intravenously with three large doses of irradiated sporozoites, and malaria-naïve individuals exposed to a single controlled mosquito bite infection. Mechanistically, we found evidence in an animal model that IgA responses were induced by sporozoites at dermal inoculation sites. From malaria-resistant individuals, we isolated several IgA monoclonal antibodies that reduced liver parasite burden in mice. One antibody, MAD2-6, bound to a conserved epitope in the amino terminus of the P. falciparum circumsporozoite protein, the dominant protein on the sporozoite surface. Crystal structures of this antibody revealed a unique mode of binding whereby two Fabs simultaneously bound either side of the target peptide. This study reveals a role for circulating IgA in malaria and identifies the amino terminus of the circumsporozoite protein as a target of functional antibodies.
Autoantibodies Inhibit Plasmodium Falciparum Growth and Are Associated with Protection from Clinical Malaria

Kelly A. Hagadorn,Mary E. Peterson,Hemanta Kole,Bethany Scott,Jeff Skinner,Ababacar Diouf,Eizo Takashima,Aissata Ongoiba,Safiatou Doumbo,Didier Doumtabe,Shanping Li,Padmapriya Sekar,Mei Yan,Chengsong Zhu,Hikaru Nagaoka,Bernard N. Kanoi,Quan-Zhen Li,Carole Long,Eric O. Long,Kassoum Kayentao,Scott A. Jenks,Ignacio Sanz,Takafumi Tsuboi,Boubacar Traore,Silvia Bolland,Kazutoyo Miura,Peter D. Crompton,Christine S. Hopp

DOI: https://doi.org/10.1016/j.immuni.2024.05.024

IF: 32.4

2024-01-01

Immunity

Abstract:Many infections, including malaria, are associated with an increase in autoantibodies (AAbs). Prior studies have reported an association between genetic markers of susceptibility to autoimmune disease and resistance to malaria, but the underlying mechanisms are unclear. Here, we performed a longitudinal study of children and adults (n = 602) in Mali and found that high levels of plasma AAbs before the malaria season independently predicted a reduced risk of clinical malaria in children during the ensuing malaria season. Baseline AAb seroprevalence increased with age and asymptomatic Plasmodium falciparum infection. We found that AAbs purified from the plasma of protected individuals inhibit the growth of blood-stage parasites and bind P. falciparum proteins that mediate parasite invasion. Protected individuals had higher plasma immunoglobulin G (IgG) reactivity against 33 of the 123 antigens assessed in an autoantigen microarray. This study provides evidence in support of the hypothesis that a propensity toward autoimmunity offers a survival advantage against malaria.
A Molecular Signature in Blood Reveals a Role for P53 in Regulating Malaria-Induced Inflammation.

Tuan M Tran,Rajan Guha,Silvia Portugal,Jeff Skinner,Aissata Ongoiba,Jyoti Bhardwaj,Marcus Jones,Jacqueline Moebius,Pratap Venepally,Safiatou Doumbo,Elizabeth A DeRiso,Shanping Li,Kamalakannan Vijayan,Sarah L Anzick,Geoffrey T Hart,Elise M O'Connell,Ogobara K Doumbo,Alexis Kaushansky,Galit Alter,Phillip L Felgner,Hernan Lorenzi,Kassoum Kayentao,Boubacar Traore,Ewen F Kirkness,Peter D Crompton

DOI: https://doi.org/10.1016/j.immuni.2019.08.009

IF: 32.4

2019-01-01

Immunity

Abstract:Immunity that controls parasitemia and inflammation during Plasmodium falciparum (Pf) malaria can be acquired with repeated infections. A limited understanding of this complex immune response impedes the development of vaccines and adjunctive therapies. We conducted a prospective systems biology study of children who differed in their ability to control parasitemia and fever following Pf infection. By integrating whole-blood transcriptomics, flow-cytometric analysis, and plasma cytokine and antibody profiles, we demonstrate that a pre-infection signature of B cell enrichment, upregulation of T helper type 1 (Th1) and Th2 cell-associated pathways, including interferon responses, and p53 activation associated with control of malarial fever and coordinated with Pf-specific immunoglobulin G (IgG) and Fc receptor activation to control parasitemia. Our hypothesis-generating approach identified host molecules that may contribute to differential clinical outcomes during Pf infection. As a proof of concept, we have shown that enhanced p53 expression in monocytes attenuated Plasmodium-induced inflammation and predicted protection from fever.
Dendritic cell responses to Plasmodium falciparum in a malaria-endemic setting

Triniti C. Turner,Charles Arama,Aissata Ongoiba,Safiatou Doumbo,Didier Doumtabé,Kassoum Kayentao,Jeff Skinner,Shanping Li,Boubacar Traore,Peter D. Crompton,Anton Götz

DOI: https://doi.org/10.21203/rs.3.rs-72313/v2

2020-01-01

Abstract:Abstract Background: Plasmodium falciparum causes the majority of malaria cases world-wide, mostly affecting children in sub-Saharan Africa. Non-sterile clinical immunity that protects from symptoms develops slowly and is relatively short-lived. Moreover, current malaria vaccine candidates fail to induce durable high-level protection in endemic settings, possibly due to the immunomodulatory effects of the malaria parasite itself. Because dendritic cells play a crucial role in initiating immune responses, here we sought to better understand the impact of cumulative malaria exposure as well as concurrent P. falciparum infection on dendritic cell phenotype and function.Methods: In this cross-sectional study we assessed the phenotype and function of dendritic cells freshly isolated from peripheral blood samples of Malian adults with a lifelong history of malaria exposure who were either uninfected (n=27) or asymptomatically infected with P. falciparum (n=8). Additionally, we measured plasma cytokine and chemokine levels in these adults and in Malian children (n=19) with acute symptomatic malaria.Results: With the exception of lower plasmacytoid dendritic cell frequencies in asymptomatically infected Malian adults, peripheral blood dendritic cell subset frequencies and HLA-DR surface expression did not differ by infection status. Peripheral blood myeloid dendritic cells of uninfected Malian adults responded to in vitro stimulation with P. falciparum blood-stage parasites by up-regulating the costimulatory molecules HLA-DR, CD80, CD86 and CD40 and secreting IL-10, CXCL9 and CXCL10. In contrast, myeloid dendritic cells of asymptomatically infected Malian adults exhibited no significant responses above the uninfected red blood cell control. IL-10 and CXCL9 plasma levels were elevated in both asymptomatic adults and children with acute malaria.Conclusions: Our findings indicate that myeloid dendritic cells of uninfected adults with a lifelong history of malaria exposure are able to up-regulate co-stimulatory molecules and produce cytokines. Whether mDCs of malaria-exposed individuals are efficient antigen-presenting cells capable of mounting an appropriate immune response remains to be determined. The data also highlights IL-10 and CXCL9 as important factors in both asymptomatic and acute malaria and add to our understanding of asymptomatic P. falciparum infections in malaria-endemic areas.
Longitudinal Analysis of Naturally Acquired PfEMP1 CIDR Domain Variant Antibodies Identifies Associations with Malaria Protection.

Nyamekye Obeng-Adjei,Daniel B. Larremore,Louise Turner,Aissata Ongoiba,Shanping Li,Safiatou Doumbo,Takele B. Yazew,Kassoum Kayentao,Louis H. Miller,Boubacar Traore,Susan K. Pierce,Caroline O. Buckee,Thomas Lavstsen,Peter D. Crompton,Tuan M. Tran

DOI: https://doi.org/10.1172/jci.insight.137262

IF: 9.4958

2020-01-01

JCI Insight

Abstract:BACKGROUND. Malaria pathogenicity is determined, in part, by the adherence of Plasmodium falciparum-infected erythrocytes to the microvasculature mediated via specific interactions between P. falciparum erythrocyte membrane protein (PfEMP1) variant domains and host endothelial receptors. Naturally acquired antibodies against specific PfEMP1 variants can play an important role in clinical protection against malaria. METHODS. We evaluated IgG responses against a repertoire of PfEMP1 CIDR domain variants to determine the rate and order of variant-specific antibody acquisition and their association with protection against febrile malaria in a prospective cohort study conducted in an area of intense, seasonal malaria transmission. RESULTS. Using longitudinal data, we found that IgG antibodies against the pathogenic domain variants CIDR alpha 1.7 and CIDR alpha 1.8 were acquired the earliest. Furthermore, IgG antibodies against CIDR gamma 3 were associated with reduced prospective risk of febrile malaria and recurrent malaria episodes. CONCLUSION. This study provides evidence that acquisition of IgG antibodies against PfEMP1 variants is ordered and demonstrates that antibodies against CIDR alpha 1 domains are acquired the earliest in children residing in an area of intense, seasonal malaria transmission. Future studies will need to validate these findings in other transmission settings and determine the functional activity of these naturally acquired CIDR variant-specific antibodies. TRIAL REGISTRATION. ClinicalTrials.gov NCT01322581. FUNDING. Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH.
128A Whole-Blood Transcriptional Signature Predicts Parasite Control and Protection from Malaria Fever During Natural Plasmodium Falciparum Infection

Tuan M. Tran,Aissata Ongoiba,Marcus Jones,Jeff Skinner,Shanping Li,Safiatou Doumbo,Didier Doumtabe,Younoussou Kone,Aboudramane Bathily,Jules Sangala,Ogobara K. Doumbo,Pratap Venepally,Kassoum Kayentao,Boubacar Traore,Ewen F. Kirkness,Peter D. Crompton

DOI: https://doi.org/10.1093/ofid/ofu051.36

2014-01-01

Open Forum Infectious Diseases

Abstract:128. A whole-blood transcriptional signature predicts parasite control and protection from malaria fever during natural Plasmodium falciparum infection Tuan M. Tran, MD, PhD; Aissata Ongoiba, MD; Marcus Jones, PhD; Jeff Skinner, MS; Shanping Li, MS; Safiatou Doumbo, MD; Didier Doumtabe, PharmD; Younoussou Kone, MD; Aboudramane Bathily, MD; Jules Sangala, MD; Ogobara K. Doumbo, MD, PhD; Pratap Venepally, PhD; Kassoum Kayentao, MD, MPH; Boubacar Traore, PharmD, PhD; Ewen F. Kirkness, PhD; Peter D. Crompton, MD, MPH; Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD; Mali International Center of Excellence in Research, Bamako, Mali; Genomic Medicine Group, J. Craig Venter Institute, Rockville, MD
Plasmodium Falciparum-Specific IgM B Cells Dominate in Children, Expand with Malaria and Produce Parasite Inhibitory IgM

Christine S. Hopp,Ababacar Diouf,Kazutoyo Miura,Kristin Boswell,Padmapriya Sekar,Jeff Skinner,Christopher M. Tipton,Michael Chambers,Sarah Andrews,Joshua Tan,Shanping Li,Safiatou Doumbo,Kassoum Kayentao,Aissata Ongoiba,Boubacar Traore,Silvia Portugal,Carole Long,Richard A. Koup,Eric Long,Adrian B. McDermott,Peter D. Crompton

DOI: https://doi.org/10.1101/2020.04.12.030049

2020-01-01

Abstract:IgG antibodies are known to play a central role in naturally acquired immunity to blood-stage malaria in humans, but little is known about the IgM response to blood-stage malaria, the mechanisms by which IgM may protect, or the underlying biology of Plasmodium falciparum ( Pf )-specific IgM B cells. In a Mali cohort spanning infants to adults we conducted a longitudinal analysis of B cells specific for the Pf blood-stage antigens AMA1 and MSP1, as well as the comparator antigen influenza hemagglutinin (HA). At the uninfected baseline, before the malaria season, Pf -specific memory B cells (MBCs) in children are disproportionally IgM+ and only gradually shift to IgG+ with age, in contrast to HA-specific MBCs that are predominantly IgG+ from infancy to adulthood. In response to acute febrile malaria, Pf- specific IgM B cells increase in frequency and upregulate activation and co-stimulatory markers. B cell receptor (BCR) analysis showed that Pf -specific IgM B cells are somatically hypermutated at levels comparable to HA-specific IgG B cells. Finally, IgM antibodies from the plasma of malaria-exposed individuals were comparable to IgG in inhibiting Pf blood-stage growth in vitro , and significantly better at enhancing phagocytosis of Pf merozoites, suggesting that IgM may protect through both direct neutralization and opsonization. Thus, somatically hypermutated Pf -specific IgM MBCs dominate in early life, are activated and expand during acute malaria and are associated with plasma IgM that inhibits parasite growth in vitro . ### Competing Interest Statement The authors have declared no competing interest.
Susceptibility to febrile malaria is associated with an inflammatory gut microbiome

Nathan Schmidt,Kristin Van Den Ham,Layne Bower,Shanping Li,Hernan Lorenzi,Safiatou Doumbo,Didier Doumtabe,Kassoum Kayentao,Aissata Ongoiba,Boubacar Traore,Peter Crompton

DOI: https://doi.org/10.21203/rs.3.rs-3974068/v1

2024-04-04

Abstract:Malaria is a major public health problem, but many of the factors underlying the pathogenesis of this disease are not well understood. Here, we demonstrate in Malian children that susceptibility to febrile malaria following infection with Plasmodium falciparum is associated with the composition of the gut microbiome prior to the malaria season. Gnotobiotic mice colonized with the fecal samples of malaria-susceptible children had a significantly higher parasite burden following Plasmodium infection compared to gnotobiotic mice colonized with the fecal samples of malaria-resistant children. The fecal microbiome of the susceptible children was enriched for bacteria associated with inflammation, mucin degradation, gut permeability and inflammatory bowel disorders (e.g., Ruminococcus gauvreauii, Ruminococcus torques, Dorea formicigenerans, Dorea longicatena, Lachnoclostridium phocaeense and Lachnoclostridium sp. YL32). However, the susceptible children also had a greater abundance of bacteria known to produce anti-inflammatory short-chain fatty acids and those associated with favorable prognosis and remission following dysbiotic intestinal events (e.g., Anaerobutyricum hallii, Blautia producta and Sellimonas intestinalis). Metabolomics analysis of the human fecal samples corroborated the existence of inflammatory and recovery-associated features within the gut microbiome of the susceptible children. There was an enrichment of nitric oxide-derived DNA adducts (deoxyinosine and deoxyuridine) and long-chain fatty acids, the absorption of which has been shown to be inhibited by inflamed intestinal epithelial cells, and a decrease in the abundance of mucus phospholipids. Nevertheless, there were also increased levels of pseudouridine and hypoxanthine, which have been shown to be regulated in response to cellular stress and to promote recovery following injury or hypoxia. Overall, these results indicate that the gut microbiome may contribute malaria pathogenesis and suggest that therapies targeting intestinal inflammation could decrease malaria susceptibility.
The gut microbiome is associated with susceptibility to febrile malaria in Malian children

Kristin M. Van Den Ham,Layne K. Bower,Shanping Li,Hernan Lorenzi,Safiatou Doumbo,Didier Doumtabe,Kassoum Kayentao,Aissata Ongoiba,Boubacar Traore,Peter D. Crompton,Nathan W. Schmidt

DOI: https://doi.org/10.1038/s41467-024-52953-8

IF: 16.6

2024-11-07

Nature Communications

Abstract:Malaria is a major public health problem, but many of the factors underlying the pathogenesis of this disease are not well understood, including protection from the development of febrile symptoms, which is observed in individuals residing in areas with moderate-to-high transmission by early adolescence. Here, we demonstrate that susceptibility to febrile malaria following Plasmodium falciparum infection is associated with the composition of the gut microbiome prior to the malaria season in 10-year-old Malian children, but not in younger children. Gnotobiotic mice colonized with the fecal samples of malaria-susceptible children were shown to have a significantly higher parasite burden following Plasmodium infection compared to gnotobiotic mice colonized with the fecal samples of malaria-resistant children. The fecal microbiome of the susceptible children was determined to be enriched for bacteria associated with inflammation, mucin degradation and gut permeability, and to have increased levels of nitric oxide-derived DNA adducts and lower levels of mucus phospholipids compared to the resistant children. Overall, these results indicate that the composition of the gut microbiome is associated with the prospective risk of febrile malaria in Malian children and suggest that modulation of the gut microbiome could decrease malaria morbidity in endemic areas.

multidisciplinary sciences
Gut Microbiota is Essential in PGRP-LA Regulated Immune Protection Against Plasmodium Berghei Infection

Li Gao,Xiumei Song,Jingwen Wang

DOI: https://doi.org/10.1186/s13071-019-3876-y

2020-01-01

Parasites & Vectors

Abstract:BACKGROUND:Malaria remains to be one of the deadliest infectious diseases and imposes substantial financial and social costs in the world. Mosquitoes rely on the immune system to control parasite infection. Peptidoglycan recognition proteins (PGRPs), a family of pattern-recognition receptors (PRR), are responsible for initiating and regulating immune signaling pathways. PGRP-LA is involved in the regulation of immune defense against the Plasmodium parasite, however, the underlying mechanism needs to be further elucidated.METHODS:The spatial and temporal expression patterns of pgrp-la in Anopheles stephensi were analyzed by qPCR. The function of PGRP-LA was examined using a dsRNA-based RNA interference strategy. Western blot and periodic acid schiff (PAS) staining were used to assess the structural integrity of peritrophic matrix (PM).RESULTS:The expression of pgrp-la in An. stephensi was induced in the midgut in response to the rapid proliferating gut microbiota post-blood meal. Knocking down of pgrp-la led to the downregulation of immune effectors that control gut microbiota growth. The decreased expression of these immune genes also facilitated P. berghei infection. However, such dsLA treatment did not influence the structural integrity of PM. When gut microbiota was removed by antibiotic treatment, the regulation of PGRP-LA on immune effectors was abolished and the knock down of pgrp-la failed to increase susceptibility of mosquitoes to parasite infection.CONCLUSIONS:PGRP-LA regulates the immune responses by sensing the dynamics of gut microbiota. A mutual interaction between gut microbiota and PGRP-LA contributes to the immune defense against Plasmodium parasites in An. stephensi.
Plasmodium Falciparum Malaria Drives Epigenetic Reprogramming of Human Monocytes Toward a Regulatory Phenotype

Rajan Guha,Anna Mathioudaki,Safiatou Doumbo,Didier Doumtabe,Jeff Skinner,Gunjan Arora,Shafiuddin Siddiqui,Shanping Li,Kassoum Kayentao,Aissata Ongoiba,Judith Zaugg,Boubacar Traore,Peter D. Crompton

DOI: https://doi.org/10.1371/journal.ppat.1009430

IF: 7.464

2021-01-01

PLoS Pathogens

Abstract:In malaria-naïve children and adults, Plasmodium falciparum-infected red blood cells (Pf-iRBCs) trigger fever and other symptoms of systemic inflammation. However, in endemic areas where individuals experience repeated Pf infections over many years, the risk of Pf-iRBC-triggered inflammatory symptoms decreases with cumulative Pf exposure. The molecular mechanisms underlying these clinical observations remain unclear. Age-stratified analyses of uninfected, asymptomatic Malian individuals before the malaria season revealed that monocytes of adults produced lower levels of inflammatory cytokines (IL-1β, IL-6 and TNF) in response to Pf-iRBC stimulation compared to monocytes of Malian children and malaria-naïve U.S. adults. Moreover, monocytes of Malian children produced lower levels of IL-1β and IL-6 following Pf-iRBC stimulation compared to 4–6-month-old infants. Accordingly, monocytes of Malian adults produced more IL-10 and expressed higher levels of the regulatory molecules CD163, CD206, Arginase-1 and TGM2. These observations were recapitulated in an in vitro system of monocyte to macrophage differentiation wherein macrophages re-exposed to Pf-iRBCs exhibited attenuated inflammatory cytokine responses and a corresponding decrease in the epigenetic marker of active gene transcription, H3K4me3, at inflammatory cytokine gene loci. Together these data indicate that Pf induces epigenetic reprogramming of monocytes/macrophages toward a regulatory phenotype that attenuates inflammatory responses during subsequent Pf exposure. Trial Registration: ClinicalTrials.gov NCT01322581.
Mast cell-derived IL-10 protects intestinal barrier integrity during malaria in mice and regulates parasite transmission to Anopheles stephensi with a female-biased immune response

Nora Céspedes,Erinn L. Donnelly,Gretchen Hansten,Abigail M. Fellows,Megan Dobson,Hannah L. Kaylor,Taylor A. Coles,Joseph Schauer,Judy Van de Water,Shirley Luckhart

DOI: https://doi.org/10.1128/iai.00360-23

2024-02-01

Infection and Immunity

Abstract:ABSTRACT Malaria is strongly predisposed to bacteremia, which is associated with increased gastrointestinal permeability and a poor clinical prognosis. We previously identified mast cells (MCs) as mediators of intestinal permeability in malaria and described multiple cytokines that rise with parasitemia, including interleukin (IL)-10, which could protect the host from an inflammatory response and alter parasite transmission to Anopheles mosquitoes. Here, we used the Cre-loxP system and non-lethal Plasmodium yoelii yoelii 17XNL to study the roles of MC-derived IL-10 in malaria immunity and transmission. Our data suggest a sex-biased and local inflammatory response mediated by MC-derived IL-10, supported by early increased number and activation of MCs in females relative to males. Increased parasitemia in female MC IL-10 (−) mice was associated with increased ileal levels of chemokines and plasma myeloperoxidase (MPO). We also observed increased intestinal permeability in female and male MC IL-10 (−) mice relative to MC IL-10 (+) mice but no differences in blood bacterial 16S DNA levels. Transmission success of P. yoelii to A. stephensi was higher in female relative to male mice and from female and male MC IL-10 (−) mice relative to MC IL-10 (+) mice. These patterns were associated with increased plasma levels of pro-inflammatory cytokines in female MC IL-10 (−) mice and increased plasma levels of chemokines and markers of neutrophil activation in male MC IL-10 (−) mice. Overall, these data suggest that MC-derived IL-10 protects intestinal barrier integrity, regulates parasite transmission, and controls local and systemic host immune responses during malaria, with a female bias.

immunology,infectious diseases
Infection-induced plasmablasts are a nutrient sink that impairs humoral immunity to malaria

Rahul Vijay,Jenna J. Guthmiller,Alexandria J. Sturtz,Fionna A. Surette,Kai J. Rogers,Ramakrishna R. Sompallae,Fengyin Li,Rosemary L. Pope,Jo-Anne Chan,Fabian de Labastida Rivera,Dean Andrew,Lachlan Webb,Wendy J. Maury,Hai-Hui Xue,Christian R. Engwerda,James S. McCarthy,Michelle J. Boyle,Noah S. Butler

DOI: https://doi.org/10.1038/s41590-020-0678-5

IF: 30.5

2020-05-18

Nature Immunology

Abstract:Plasmodium parasite–specific antibodies are critical for protection against malaria, yet the development of long-lived and effective humoral immunity against Plasmodium takes many years and multiple rounds of infection and cure. Here, we report that the rapid development of short-lived plasmablasts during experimental malaria unexpectedly hindered parasite control by impeding germinal center responses. Metabolic hyperactivity of plasmablasts resulted in nutrient deprivation of the germinal center reaction, limiting the generation of memory B cell and long-lived plasma cell responses. Therapeutic administration of a single amino acid to experimentally infected mice was sufficient to overcome the metabolic constraints imposed by plasmablasts and enhanced parasite clearance and the formation of protective humoral immune memory responses. Thus, our studies not only challenge the current model describing the role and function of blood-stage Plasmodium-induced plasmablasts but they also reveal new targets and strategies to improve anti-Plasmodium humoral immunity.

immunology
Human transcriptional signature of protection after Plasmodium falciparum immunization and infectious challenge via mosquito bites

Marie Mura,Burook Misganaw,Aarti Gautam,Tanisha Robinson,Sidhartha Chaudhury,Neha Bansal,Andrew J. Martins,John Tsang,Rasha Hammamieh,Elke Bergmann-Leitner

DOI: https://doi.org/10.1080/21645515.2023.2282693

2023-11-29

Human Vaccines & Immunotherapeutics

Abstract:The identification of immune correlates of protection against infectious pathogens will accelerate the design and optimization of recombinant and subunit vaccines. Systematic analyses such as immunoprofiling including serological, cellular, and molecular assessments supported by computational tools are key to not only identify correlates of protection but also biomarkers of disease susceptibility. The current study expands our previous cellular and serological profiling of vaccine-induced responses to a whole parasite malaria vaccine. The irradiated sporozoite model was chosen as it is considered the most effective vaccine against malaria. In contrast to whole blood transcriptomics analysis, we stimulated peripheral blood mononuclear cells (PBMC) with sporozoites and enriched for antigen-specific cells prior to conducting transcriptomics analysis. By focusing on transcriptional events triggered by antigen-specific stimulation, we were able to uncover quantitative and qualitative differences between protected and non-protected individuals to controlled human malaria infections and identified differentially expressed genes associated with sporozoite-specific responses. Further analyses including pathway and gene set enrichment analysis revealed that vaccination with irradiated sporozoites induced a transcriptomic profile associated with Th1-responses, Interferon-signaling, antigen-presentation, and inflammation. Analyzing longitudinal time points not only post-vaccination but also post-controlled human malaria infection further revealed that the transcriptomic profile of protected vs non-protected individuals was not static but continued to diverge over time. The results lay the foundation for comparing protective immune signatures induced by various vaccine platforms to uncover immune correlates of protection that are common across platforms.

immunology,biotechnology & applied microbiology
Correlative humoral and cellular immunity to genetically attenuated malaria parasites in humans

Emil Colstrup,Rie Nakajima,Jelte M. M. Krol,Olivia A. C. Lamers,Rafael Ramiro De Assis,Aarti Jain,Algis Jasinskas,Eva Iliopoulou,Helena M. de Bes-Roeleveld,Blandine M. D. Franke-Fayard,Meta Roestenberg,Philip L. Felgner,Rajagopal Murugan

DOI: https://doi.org/10.1101/2024.11.11.622940

2024-11-11

Abstract:Malaria caused by Plasmodium falciparum remains one of the major infectious diseases with a high burden in Sub-Saharan Africa. In spite of the advancements made in vaccine development and implementation in endemic countries, sterile and durable protection has not been achieved. Recently, we have shown the superior protective capacity of whole sporozoites attenuated to arrest late but not early during the liver stage development in a controlled human malaria infection study. Here we report the breadth of antigens targeted by hitherto understudied parasite liver stage immunity and convey the coherence between humoral and cellular immunity observed in our clinical study. Our findings uncover the underlying immunogenic differences between early- and late-liver stage arresting parasites and identify key liver-stage antigens for future vaccine development focused on inducing sterile immunity to malaria.

Immunology
A Gut Symbiotic Bacterium Serratia marcescens Renders Mosquito Resistance to Plasmodium Infection Through Activation of Mosquito Immune Responses

Liang Bai,Lili Wang,Joel Vega-Rodríguez,Guandong Wang,Sibao Wang

DOI: https://doi.org/10.3389/fmicb.2019.01580

IF: 5.2

2019-07-18

Frontiers in Microbiology

Abstract:The malaria development in the mosquito midgut is a complex process that results in considerable parasite losses. The mosquito gut microbiota influences the outcome of pathogen infection in mosquitoes, but the underlying mechanisms through which gut symbiotic bacteria affect vector competence remain elusive. Here, we identified two Serratia strains (Y1 and J1) isolated from field-caught female Anopheles sinensis from China and assessed their effect on Plasmodium development in An. stephensi. Colonization of An. stephensi midgut by Serratia Y1 significantly renders the mosquito resistant to Plasmodium berghei infection, while Serratia J1 has no impact on parasite development. Parasite inhibition by Serratia Y1 is induced by the activation of the mosquito immune system. Genome-wide transcriptomic analysis by RNA-seq shows a similar pattern of midgut gene expression in response to Serratia Y1 and J1 in sugar-fed mosquitoes. However, 24 h after blood ingestion, Serratia Y1 modulates more midgut genes than Serratia J1 including the c-type lectins (CTLs), CLIP serine proteases and other immune effectors. Furthermore, silencing of several Serratia Y1-induced anti-Plasmodium factors like the thioester-containing protein 1 (TEP1), fibrinogen immunolectin 9 (FBN9) or leucine-rich repeat protein LRRD7 can rescue parasite oocyst development in the presence of Serratia Y1, suggesting that these factors modulate the Serratia Y1-mediated anti-Plasmodium effect. This study enhances our understanding of how gut bacteria influence mosquito-Plasmodium interactions.

microbiology
Resistance to malaria through structural variation of red blood cell invasion receptors

Ellen M Leffler,Gavin Band,George B J Busby,Katja Kivinen,Quang Si Le,Geraldine M Clarke,Kalifa A Bojang,David J Conway,Muminatou Jallow,Fatoumatta Sisay-Joof,Edith C Bougouma,Valentina D Mangano,David Modiano,Sodiomon B Sirima,Eric Achidi,Tobias O Apinjoh,Kevin Marsh,Carolyne M Ndila,Norbert Peshu,Thomas N Williams,Chris Drakeley,Alphaxard Manjurano,Hugh Reyburn,Eleanor Riley,David Kachala,Malcolm Molyneux,Vysaul Nyirongo,Terrie Taylor,Nicole Thornton,Louise Tilley,Shane Grimsley,Eleanor Drury,Jim Stalker,Victoria Cornelius,Christina Hubbart,Anna E Jeffreys,Kate Rowlands,Kirk A Rockett,Chris C A Spencer,Dominic P Kwiatkowski,Malaria Genomic Epidemiology Network

DOI: https://doi.org/10.1126/science.aam6393

IF: 56.9

2017-06-16

Science

Abstract:The malaria parasite Plasmodium falciparum invades human red blood cells by a series of interactions between host and parasite surface proteins. By analyzing genome sequence data from human populations, including 1269 individuals from sub-Saharan Africa, we identify a diverse array of large copy-number variants affecting the host invasion receptor genes GYPA and GYPB We find that a nearby association with severe malaria is explained by a complex structural rearrangement involving the loss of GYPB and gain of two GYPB-A hybrid genes, which encode a serologically distinct blood group antigen known as Dantu. This variant reduces the risk of severe malaria by 40% and has recently increased in frequency in parts of Kenya, yet it appears to be absent from west Africa. These findings link structural variation of red blood cell invasion receptors with natural resistance to severe malaria.
Genome-wide liver transcriptomic profiling of a malaria mouse model reveals disturbed immune and metabolic responses

Xueyan Hu,Jie Zhao,Junhui Zhao,Ence Yang,Mozhi Jia

DOI: https://doi.org/10.1186/s13071-023-05672-w

2023-01-30

Abstract:Background: The liver is responsible for a range of functions in vertebrates, such as metabolism and immunity. In malaria, the liver plays a crucial role in the interaction between the parasite and host. Although malarial hepatitis is a common clinical complication of severe malaria, other malaria-related liver changes have been overlooked during the blood stage of the parasite life-cycle, in contrast to the many studies that have focused on parasite invasion of and replication in the liver during the hepatic stage of the parasite. Methods: A rodent model of malaria was established using Plasmodium yoelii strain 17XL, a lethal strain of rodent malaria, for liver transcriptomic profiling. Results: Differentially expressed messenger RNAs were associated with innate and adaptive immune responses, while differentially expressed long noncoding RNAs were enriched in the regulation of metabolism-related pathways, such as lipid metabolism. The coexpression network showed that host genes were related to cellular transport and tissue remodeling. Hub gene analysis of P. yoelii indicated that ubiquitination genes that were coexpressed with the host were evolutionarily conserved. Conclusions: Our analysis yielded evidence of activated immune responses, aberrant metabolic processes and tissue remodeling changes in the livers of mice with malaria during the blood stage of the parasite, which provided a systematic outline of liver responses during Plasmodium infection.
G6pd-Deficient Mice Are Protected From Experimental Cerebral Malaria and Liver Injury by Suppressing Proinflammatory Response in the Early Stage of Plasmodium berghei Infection

Haoan Yi,Weiyang Jiang,Fang Yang,Fan Li,Yirong Li,Wenjing Zhu,Qing Li,Syed Hassam Fakhar,Yaming Cao,Lan Luo,Wen Zhang,Yongshu He

DOI: https://doi.org/10.3389/fimmu.2021.719189

IF: 7.3

2021-08-11

Frontiers in Immunology

Abstract:Epidemiological studies provide compelling evidence that glucose-6-phosphate dehydrogenase (G6PD) deficiency individuals are relatively protected against Plasmodium parasite infection. However, the animal model studies on this subject are lacking. Plus, the underlying mechanism in vivo is poorly known. In this study, we used a G6pd-deficient mice infected with the rodent parasite Plasmodium berghei ( P.berghei ) to set up a malaria model in mice. We analyzed the pathological progression of experimental cerebral malaria (ECM) and acute liver injury in mice with different G6pd activity infected with P.berghei . We performed dual RNA-seq for host-parasite transcriptomics and validated the changes of proinflammatory response in the murine model. G6pd-deficient mice exhibited a survival advantage, less severe ECM and mild liver injury compared to the wild type mice. Analysis based on dual RNA-seq suggests that G6pd-deficient mice are protected from ECM and acute liver injury were related to proinflammatory responses. Th1 differentiation and dendritic cell maturation in the liver and spleen were inhibited in G6pd-deficient mice. The levels of proinflammatory cytokines were reduced, chemokines and vascular adhesion molecules in the brain were significantly down-regulated, these led to decreased cerebral microvascular obstruction in G6pd-deficient mice. We generated the result that G6pd-deficiency mediated protection against ECM and acute liver injury were driven by the regulatory proinflammatory responses. Furthermore, bioinformatics analyses showed that P.berghei might occur ribosome loss in G6pd-deficient mice. Our findings provide a novel perspective of the underlying mechanism of G6PD deficiency mediated protection against malaria in vivo .

immunology

Amniotic fluid interleukin-6 and the risk of early-onset sepsis among preterm infants.

Functional Human IgA Targets a Conserved Site on Malaria Sporozoites

Autoantibodies Inhibit Plasmodium Falciparum Growth and Are Associated with Protection from Clinical Malaria

A Molecular Signature in Blood Reveals a Role for P53 in Regulating Malaria-Induced Inflammation.

Dendritic cell responses to Plasmodium falciparum in a malaria-endemic setting

Longitudinal Analysis of Naturally Acquired PfEMP1 CIDR Domain Variant Antibodies Identifies Associations with Malaria Protection.

128A Whole-Blood Transcriptional Signature Predicts Parasite Control and Protection from Malaria Fever During Natural Plasmodium Falciparum Infection

Plasmodium Falciparum-Specific IgM B Cells Dominate in Children, Expand with Malaria and Produce Parasite Inhibitory IgM

Susceptibility to febrile malaria is associated with an inflammatory gut microbiome

The gut microbiome is associated with susceptibility to febrile malaria in Malian children

Gut Microbiota is Essential in PGRP-LA Regulated Immune Protection Against Plasmodium Berghei Infection

Plasmodium Falciparum Malaria Drives Epigenetic Reprogramming of Human Monocytes Toward a Regulatory Phenotype

Mast cell-derived IL-10 protects intestinal barrier integrity during malaria in mice and regulates parasite transmission to Anopheles stephensi with a female-biased immune response

Infection-induced plasmablasts are a nutrient sink that impairs humoral immunity to malaria

Human transcriptional signature of protection after Plasmodium falciparum immunization and infectious challenge via mosquito bites

Correlative humoral and cellular immunity to genetically attenuated malaria parasites in humans

A Gut Symbiotic Bacterium Serratia marcescens Renders Mosquito Resistance to Plasmodium Infection Through Activation of Mosquito Immune Responses

Resistance to malaria through structural variation of red blood cell invasion receptors

Genome-wide liver transcriptomic profiling of a malaria mouse model reveals disturbed immune and metabolic responses

G6pd-Deficient Mice Are Protected From Experimental Cerebral Malaria and Liver Injury by Suppressing Proinflammatory Response in the Early Stage of Plasmodium berghei Infection